Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Sh. Z. Archuadze"'
Autor:
M. A. Kolganova, N. S. Bagaeva, Yu. V. Medvedev, I. E. Shohin, A. V. Demchinskaya, T. N. Palkina, D. A. Salazanov, G. E. Konopleva, M. S. Sheremeteva, Sh. Z. Archuadze, Ya. V. Lavrovsky, A. Yu. Savchenko, M. Yu. Samsonov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 8, Iss 3, Pp 91-100 (2019)
Introduction. Bevacizumab is a monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab is used as a targeted monoor combination therapy for different solid tumors. Phas
Externí odkaz:
https://doaj.org/article/6934a7f8205e43d19cd8c3495b30f189
